JP2017513809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513809A5 JP2017513809A5 JP2016552499A JP2016552499A JP2017513809A5 JP 2017513809 A5 JP2017513809 A5 JP 2017513809A5 JP 2016552499 A JP2016552499 A JP 2016552499A JP 2016552499 A JP2016552499 A JP 2016552499A JP 2017513809 A5 JP2017513809 A5 JP 2017513809A5
- Authority
- JP
- Japan
- Prior art keywords
- steady state
- dose
- pharmaceutical composition
- testosterone
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 18
- 229960003604 testosterone Drugs 0.000 claims description 18
- 230000036470 plasma concentration Effects 0.000 claims description 13
- 230000036765 blood level Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 238000007918 intramuscular administration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461941875P | 2014-02-19 | 2014-02-19 | |
| US61/941,875 | 2014-02-19 | ||
| PCT/US2015/016505 WO2015127012A1 (en) | 2014-02-19 | 2015-02-19 | Needle assisted jet injection administration of testosterone compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019237675A Division JP2020073545A (ja) | 2014-02-19 | 2019-12-27 | テストステロン組成物の針に補助されるジェット注射投与 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513809A JP2017513809A (ja) | 2017-06-01 |
| JP2017513809A5 true JP2017513809A5 (OSRAM) | 2018-03-29 |
Family
ID=53878936
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552499A Withdrawn JP2017513809A (ja) | 2014-02-19 | 2015-02-19 | テストステロン組成物の針に補助されるジェット注射投与 |
| JP2019237675A Pending JP2020073545A (ja) | 2014-02-19 | 2019-12-27 | テストステロン組成物の針に補助されるジェット注射投与 |
| JP2023007294A Pending JP2023052550A (ja) | 2014-02-19 | 2023-01-20 | テストステロン組成物の針に補助されるジェット注射投与 |
| JP2025015053A Pending JP2025072449A (ja) | 2014-02-19 | 2025-01-31 | テストステロン組成物の針に補助されるジェット注射投与 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019237675A Pending JP2020073545A (ja) | 2014-02-19 | 2019-12-27 | テストステロン組成物の針に補助されるジェット注射投与 |
| JP2023007294A Pending JP2023052550A (ja) | 2014-02-19 | 2023-01-20 | テストステロン組成物の針に補助されるジェット注射投与 |
| JP2025015053A Pending JP2025072449A (ja) | 2014-02-19 | 2025-01-31 | テストステロン組成物の針に補助されるジェット注射投与 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10238662B2 (OSRAM) |
| EP (2) | EP4062918A1 (OSRAM) |
| JP (4) | JP2017513809A (OSRAM) |
| CA (1) | CA2939791C (OSRAM) |
| WO (1) | WO2015127012A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4062918A1 (en) * | 2014-02-19 | 2022-09-28 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
| US11116911B2 (en) * | 2016-04-11 | 2021-09-14 | Biogen Ma, Inc. | Injector lockout prevention device |
| JP2021502814A (ja) | 2017-11-14 | 2021-02-04 | クック・バイオテック・インコーポレイテッドＣｏｏｋ Ｂｉｏｔｅｃｈ Ｉｎｃｏｒｐｏｒａｔｅｄ | 保存組織製品および関連する方法 |
| WO2019099527A1 (en) * | 2017-11-14 | 2019-05-23 | Cook Biotech Incorporated | Sterilized tissue products and related methods |
| JP7194756B2 (ja) | 2018-06-08 | 2022-12-22 | アンタレス・ファーマ・インコーポレーテッド | 自動挿入注射器 |
| CA3204309A1 (en) | 2018-07-24 | 2020-02-20 | Antares Pharma, Inc. | Injector with safety cap |
| CN111110959B (zh) * | 2020-02-06 | 2021-08-13 | 周冬兵 | 一种医疗领域使用的注射器 |
| EP4230241B1 (en) * | 2020-10-16 | 2025-03-12 | Shandong Wego Prefills Pharmaceutical Packaging Co., Ltd. | Automatic syringe |
| EP4173656A1 (en) | 2021-10-27 | 2023-05-03 | medmix Switzerland AG | Needle guard, drug delivery device and method for manufacturing |
| EP4588495A1 (en) * | 2022-09-13 | 2025-07-23 | Daicel Corporation | Injector, and method for injecting solution using said injector |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428528B2 (en) | 1998-08-11 | 2002-08-06 | Antares Pharma, Inc. | Needle assisted jet injector |
| US6391003B1 (en) | 1999-10-25 | 2002-05-21 | Antares Pharma, Inc. | Locking mechanism for a jet injector |
| AU2003209095A1 (en) | 2002-02-11 | 2003-09-04 | Antares Pharma, Inc. | Intradermal injector |
| US7449012B2 (en) | 2004-08-06 | 2008-11-11 | Meridian Medical Technologies, Inc. | Automatic injector |
| DK1850892T4 (da) | 2005-01-24 | 2023-06-06 | Antares Pharma Inc | Forfyldt nål-assisteret sprøjtejetinjektor |
| US20100144687A1 (en) * | 2008-12-05 | 2010-06-10 | Glaser Rebecca L | Pharmaceutical compositions containing testosterone and an aromatase inhibitor |
| EP2408493B1 (en) | 2009-03-20 | 2024-07-24 | Antares Pharma, Inc. | Hazardous agent injection system |
| JP6152092B2 (ja) * | 2011-05-15 | 2017-06-28 | エーセラス ファーマシューティカルズ コーポレーション | 経鼻投与のための徐放テストステロン鼻腔内ゲル、方法および複数回用量プレフィルアプリケーターシステム |
| US9950125B2 (en) * | 2012-04-06 | 2018-04-24 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
| US20140171918A1 (en) * | 2012-12-14 | 2014-06-19 | Bioject, Inc. | Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men |
| EP4382165A3 (en) * | 2013-10-07 | 2024-08-21 | Antares Pharma, Inc. | Hematocrit modulation through needle assisted jet injection of testosterone |
| EP4062918A1 (en) * | 2014-02-19 | 2022-09-28 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
-
2015
- 2015-02-19 EP EP21216627.6A patent/EP4062918A1/en active Pending
- 2015-02-19 EP EP15751481.1A patent/EP3107547A4/en not_active Ceased
- 2015-02-19 WO PCT/US2015/016505 patent/WO2015127012A1/en not_active Ceased
- 2015-02-19 CA CA2939791A patent/CA2939791C/en active Active
- 2015-02-19 US US15/119,344 patent/US10238662B2/en active Active
- 2015-02-19 JP JP2016552499A patent/JP2017513809A/ja not_active Withdrawn
-
2019
- 2019-02-01 US US16/265,531 patent/US10912782B2/en active Active
- 2019-12-27 JP JP2019237675A patent/JP2020073545A/ja active Pending
-
2021
- 2021-01-25 US US17/157,310 patent/US11844804B2/en active Active
-
2023
- 2023-01-20 JP JP2023007294A patent/JP2023052550A/ja active Pending
- 2023-11-06 US US18/502,166 patent/US20240091239A1/en active Pending
-
2025
- 2025-01-31 JP JP2025015053A patent/JP2025072449A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513809A5 (OSRAM) | ||
| JP2017503820A5 (OSRAM) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2016528302A5 (OSRAM) | ||
| JP2018507243A5 (OSRAM) | ||
| JP2016510326A5 (OSRAM) | ||
| PH12019500154A1 (en) | Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | |
| JP2017503014A5 (OSRAM) | ||
| JP2016516773A5 (OSRAM) | ||
| JP2018510894A5 (OSRAM) | ||
| JP2019532047A5 (OSRAM) | ||
| JP2013537915A5 (OSRAM) | ||
| JP2017533220A5 (OSRAM) | ||
| JP2012502103A5 (OSRAM) | ||
| JP2017503846A5 (OSRAM) | ||
| JP2015522603A5 (OSRAM) | ||
| EP4410295A3 (en) | Use of vibegron to treat overactive bladder | |
| HK1255584A1 (zh) | 使用阿坎酸及d-环丝胺酸的联合疗法 | |
| JP2019507786A5 (OSRAM) | ||
| JP2016512247A5 (OSRAM) | ||
| JP2016505050A5 (OSRAM) | ||
| JP2019511506A5 (OSRAM) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| FI3352735T3 (fi) | Pitkitetysti vapauttavia olantsapiiniformulaatioita | |
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 |